NDC 72789-528
Minocycline Hydrochloride 105 mg tablet, film coated, extended release
On the label: PD-Rx Pharmaceuticals, Inc.. It's repackaged: PD-Rx Pharmaceuticals, Inc. rebottles it from Ascend Laboratories, LLC's NDC 67877-438.
Where the pills inside were made
| Factory | Where | Role | Last FDA inspection |
|---|---|---|---|
| Alkem Laboratories Limited | Amaliya Daman, India | Makes it, tests it and packages it | No problems foundAug 30, 2019 · 6 inspections |
Repackaging site
- PD-Rx Pharmaceuticals Inc., Oklahoma City, OK, United States · repackages it
Recalls
- Jun 1, 2026 · Class II · Ascend Laboratories, LLC
Failed Dissolution Specifications: An out-of-specification (OOS) result was observed during the 9th month of dissolution test analysis
Lots: Lot# 25141635, Exp 4/30/2028 - Jan 22, 2020 · Class III · Ascend Laboratories LLC
Failed Dissolution Specifications: low out of specification results for dissolution testing.
Lots: Lot #: 19140414, Exp 12/2020
Class I recalls are the most serious; Class III the least. A recall covers specific lots, listed on each recall.
Product details
- Generic drug
- Minocycline: every company that makes it
- Form
- tablet, film coated, extended release, oral
- Strength
- 105 mg
- Approval
- ANDA ANDA204453
- On the market since
- Sep 30, 2016
- Package NDCs
72789-528-30- Official label
- DailyMed (National Library of Medicine), updated Jul 31, 2026
Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?